Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.120
-0.010 (-0.88%)
At close: May 22, 2026, 4:00 PM EDT
1.130
+0.010 (0.89%)
After-hours: May 22, 2026, 7:45 PM EDT
Organigram Global Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Organigram Global stock have an average target of $3.26, which predicts a 191.07% increase from the current stock price of 1.12.
Price Target: $3.26 (+191.07%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Organigram Global stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '23 | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $1.25 → $4.00 | Strong Buy | Maintains | $1.25 → $4.00 | +257.14% | Jul 17, 2023 |
| CIBC | CIBC | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | May 11, 2021 |
| CIBC | CIBC | Hold → Sell Downgrades $20 → $13 | Hold → Sell | Downgrades | $20 → $13 | +1,060.71% | Apr 14, 2021 |
| BMO Capital | BMO Capital | Hold → Sell Downgrades $8 | Hold → Sell | Downgrades | $8 | +614.29% | Mar 10, 2021 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 12, 2019 |
Financial Forecast
Revenue This Year
322.37M
from 259.18M
Increased by 24.38%
Revenue Next Year
385.32M
from 322.37M
Increased by 19.53%
EPS This Year
0.20
from -0.19
EPS Next Year
0.07
from 0.20
Decreased by -66.25%
Financial currency is CAD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 363.4M | 474.2M | |||||
| Avg | 322.4M | 385.3M | |||||
| Low | 293.8M | 311.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 40.2% | 47.1% | |||||
| Avg | 24.4% | 19.5% | |||||
| Low | 13.4% | -3.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.22 | 0.09 | |
| Avg | 0.20 | 0.07 | |
| Low | 0.19 | 0.05 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | -55.8% | |
| Avg | - | -66.3% | |
| Low | - | -75.7% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.